← All trials
NCT00350298
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2006
- Primary completion
- Jul 1, 2008
- Completion date
- Oct 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of MassachusettsLead sponsor
- University of KentuckyOverall official - principal investigator
- Henry Ford Health SystemOverall official - principal investigator
- Mayo ClinicOverall official - principal investigator
- Remington-Davis Clinical ResearchOverall official - principal investigator
- Centre Hospitalier Regional de Trois-RivieresOverall official - principal investigator
- Idaho Falls Infectious Diseases, PLLCOverall official - principal investigator
- Vancouver Island Health Research CentreOverall official - principal investigator
- Windsor Regional HospitalOverall official - principal investigator
- Central Indiana Gastroenterology GroupOverall official - principal investigator
- Dr. Kiran C. Patel Research InstituteOverall official - principal investigator
- Chest, Infectious Diseases and Critical Care Assoc., PCOverall official - principal investigator
- Mercury Street Medical GroupOverall official - principal investigator
- Baylor UniversityOverall official - principal investigator
- PMG ResearchOverall official - principal investigator
- Centre de Sante et de Services Sociaux de ChicoutimiOverall official - principal investigator
- Kaiser PermanenteOverall official - principal investigator
- University of CalgaryOverall official - principal investigator
- University of ManitobaOverall official - principal investigator
- Rapid City Regional HospitalOverall official - principal investigator
- Saint Luke's Health SystemOverall official - principal investigator
- Queen's University, BelfastOverall official - principal investigator
- Summa Health SystemOverall official - principal investigator
- University of California, Los AngelesOverall official - principal investigator
- Jersey Shore University Medical CenterOverall official - principal investigator
- MedarexCollaborator
- Thomas Jefferson UniversityOverall official - principal investigator
- MultiCare Health System Research InstituteOverall official - principal investigator
- Texas A&M UniversityOverall official - principal investigator
- University of Southern CaliforniaOverall official - principal investigator
- Icahn School of Medicine at Mount SinaiOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.